TY - JOUR
T1 - Application of magnetic iron oxide nanoparticles
T2 - Thrombotic activity, imaging and cytocompatibility of silica-coated and carboxymethyl dextrane-coated particles
AU - Turrina, Chiara
AU - Schoenen, Max
AU - Milani, Davide
AU - Klassen, Anna
AU - Rojas Gonzaléz, Diana M.
AU - Cvirn, Gerhard
AU - Mela, Petra
AU - Berensmeier, Sonja
AU - Slabu, Ioana
AU - Schwaminger, Sebastian P.
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2023/8
Y1 - 2023/8
N2 - Coated iron oxide nanoparticles (IONs) are promising candidates for various applications in nanomedicine, including imaging, magnetic hyperthermia, and drug delivery. The application of IONs in nanomedicine is influenced by factors such as biocompatibility, surface properties, agglomeration, degradation behavior, and thrombogenicity. Therefore, it is essential to investigate the effects of coating material and thickness on the behavior and performance of IONs in the human body. In this study, IONs with a carboxymethyl dextran (CMD) coating and two thicknesses of silica coating (TEOS0.98, and TEOS3.91) were screened and compared to bare iron oxide nanoparticles (BIONs). All three coated particles showed good cytocompatibility (>70%) when tested with smooth muscle cells over three days. To investigate their potential long term behavior inside the human body, the Fe2+ release and hydrodynamic diameters of silica-coated and CMD (carboxymethyl dextrane)-coated IONs were analyzed in simulated body fluids for 72 h at 37 °C. The ION@CMD showed moderate agglomeration of around 100 nm in all four simulated fluids and dissolved faster than the silica-coated particles in artificial exosomal fluid and artificial lysosomal fluid. The particles with silica coating agglomerated in all tested simulated media above 1000 nm. Increased thickness of the silica coating led to decreased degradation of particles. Additionally, CMD coating resulted in nanoparticles with the least prothrombotic activity, and the thick silica coating apparently decreased the prothrombotic properties of nanoparticles compared to BIONs and [email protected]. For magnetic resonance applications, ION@CMD and [email protected] showed comparatively high relaxation rates R2 values. In magnetic particle imaging experiments [email protected] yielded the highest normalized signal to noise ratio values and in magnetic hyperthermia studies, ION@CMD and [email protected] showed similar specific loss power. These findings demonstrate the potential of coated IONs in nanomedicine and emphasize the importance of understanding the effect of coating material and thickness on their behavior and performance in the human body.
AB - Coated iron oxide nanoparticles (IONs) are promising candidates for various applications in nanomedicine, including imaging, magnetic hyperthermia, and drug delivery. The application of IONs in nanomedicine is influenced by factors such as biocompatibility, surface properties, agglomeration, degradation behavior, and thrombogenicity. Therefore, it is essential to investigate the effects of coating material and thickness on the behavior and performance of IONs in the human body. In this study, IONs with a carboxymethyl dextran (CMD) coating and two thicknesses of silica coating (TEOS0.98, and TEOS3.91) were screened and compared to bare iron oxide nanoparticles (BIONs). All three coated particles showed good cytocompatibility (>70%) when tested with smooth muscle cells over three days. To investigate their potential long term behavior inside the human body, the Fe2+ release and hydrodynamic diameters of silica-coated and CMD (carboxymethyl dextrane)-coated IONs were analyzed in simulated body fluids for 72 h at 37 °C. The ION@CMD showed moderate agglomeration of around 100 nm in all four simulated fluids and dissolved faster than the silica-coated particles in artificial exosomal fluid and artificial lysosomal fluid. The particles with silica coating agglomerated in all tested simulated media above 1000 nm. Increased thickness of the silica coating led to decreased degradation of particles. Additionally, CMD coating resulted in nanoparticles with the least prothrombotic activity, and the thick silica coating apparently decreased the prothrombotic properties of nanoparticles compared to BIONs and [email protected]. For magnetic resonance applications, ION@CMD and [email protected] showed comparatively high relaxation rates R2 values. In magnetic particle imaging experiments [email protected] yielded the highest normalized signal to noise ratio values and in magnetic hyperthermia studies, ION@CMD and [email protected] showed similar specific loss power. These findings demonstrate the potential of coated IONs in nanomedicine and emphasize the importance of understanding the effect of coating material and thickness on their behavior and performance in the human body.
KW - Agglomeration behavior
KW - Coagulation
KW - Iron oxide nanoparticles
KW - Magnetic resonance imaging
KW - Magnetic separation
KW - Nanomedicine
UR - http://www.scopus.com/inward/record.url?scp=85162935194&partnerID=8YFLogxK
U2 - 10.1016/j.colsurfb.2023.113428
DO - 10.1016/j.colsurfb.2023.113428
M3 - Article
AN - SCOPUS:85162935194
SN - 0927-7765
VL - 228
JO - Colloids and Surfaces B: Biointerfaces
JF - Colloids and Surfaces B: Biointerfaces
M1 - 113428
ER -